Maintaining Mb heme-iron in a chemically reduced (Fe2+) state also appears to ameliorate AKI and renal dysfunction, and may explain the positive effects of endogenous antioxidant replacement, and also some of the action of desferrioxamine that can reduce Mb heme [23]. This evidence concerns the gene MB and acute kidney injury.